Caribou Biosciences, Inc. (CRBU)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 341.39M |
| Enterprise value | 39.67M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.09 |
| Price/book (mrq) | 0.93 |
| Enterprise value/revenue | 1.15 |
| Enterprise value/EBITDA | -0.35 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.47 |
| 52-week change 3 | -9.35% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 8.5900 |
| 52-week low 3 | 3.4400 |
| 50-day moving average 3 | 5.4947 |
| 200-day moving average 3 | 5.5744 |
Share statistics
| Avg vol (3-month) 3 | 1.62M |
| Avg vol (10-day) 3 | 1.39M |
| Shares outstanding 5 | 90.31M |
| Implied shares outstanding 6 | 90.31M |
| Float 8 | 68.48M |
| % held by insiders 1 | 10.14% |
| % held by institutions 1 | 78.07% |
| Shares short (15 Apr 2024) 4 | 11.34M |
| Short ratio (15 Apr 2024) 4 | 6.71 |
| Short % of float (15 Apr 2024) 4 | 13.16% |
| Short % of shares outstanding (15 Apr 2024) 4 | 12.56% |
| Shares short (prior month 15 Mar 2024) 4 | 10.07M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -296.05% |
| Operating margin (ttm) | -1,052.33% |
Management effectiveness
| Return on assets (ttm) | -18.00% |
| Return on equity (ttm) | -30.50% |
Income statement
| Revenue (ttm) | 34.48M |
| Revenue per share (ttm) | 0.47 |
| Quarterly revenue growth (yoy) | -3.60% |
| Gross profit (ttm) | N/A |
| EBITDA | -112.53M |
| Net income avi to common (ttm) | -102.07M |
| Diluted EPS (ttm) | -1.3800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 328.83M |
| Total cash per share (mrq) | 3.64 |
| Total debt (mrq) | 27.11M |
| Total debt/equity (mrq) | 7.36% |
| Current ratio (mrq) | 11.97 |
| Book value per share (mrq) | 4.16 |
Cash flow statement
| Operating cash flow (ttm) | -93.29M |
| Levered free cash flow (ttm) | -64.36M |
© 2024 Yahoo. All rights reserved.